Accueil > Revues > Médecine > European Journal of Dermatology > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
European Journal of Dermatology
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Biologie et recherche
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable
  Version PDF

Pre-testing in hair dye users: an assessment of the Colourstart™ system


European Journal of Dermatology. Volume 19, Numéro 3, 232-7, May-June 2009, Investigative report

DOI : 10.1684/ejd.2009.0645

Summary  

Auteur(s) : David A Basketter, John English , DABMEB Consultancy, Sharnbrook, Bedfordshire, UK, Department of Dermatology, Nottingham University Hospital, Nottingham, UK.

Illustrations

ARTICLE

Auteur(s) : David A Basketter1, John English2

1DABMEB Consultancy, Sharnbrook, Bedfordshire, UK
2Department of Dermatology, Nottingham University Hospital, Nottingham, UK

accepté le 1 Janvier 2009

Consumer and occupational exposure to skin sensitising ingredients contained in nearly all hair dyes has long been associated with a history of allergic contact dermatitis (ACD) [1-4]. The primary culprit in this respect has been recognised for many years to be p-phenylenediamine (PPD), although precise details of its chemical mechanism of sensitisation remain the subject of investigation [2, 4, 5]. Through its routine use in almost all standard patch test batteries, the frequency with which it gives rise to a positive patch test in consecutive patients has been described in many countries [6-9]. How this translates into a frequency of allergy in the general adult population is a matter of inexact extrapolation, but seems likely to be in the order of 1%-3%. Whilst a good proportion of these individuals, for a variety of reasons, may not express ACD when exposed to PPD during hair dyeing, it is evident that a significant number do suffer from hair dye elicited eczema [10-12]. Furthermore, a modest proportion of them experience adverse reactions to a degree that is beyond a mild itchy rash, but rather is a more serious eczema and is sometimes associated with a substantial degree of oedema, particularly of the face and hand, often requiring a period of hospitalisation [12-16].

The manufacturers of hair dyes have long recognised that their products can cause allergy and whilst they might contest the details of the frequency with which this occurs, for decades they have recommended the use of a skin sensitivity test prior to each use of hair dye. It is not the purpose of this paper to debate the appropriateness of this recommendation. Rather it is to address whether one particular approach has the potential to work in practice. At present, there is no standardised system in place. One major manufacturer has published details of how it considers sensitivity testing should be undertaken and completed a study in PPD allergic volunteers to demonstrate its utility [17, 18]. However, as far as the present authors are aware, the use of this method in hair dyeing salons, at least in the UK, is very low (probably < 10%). One reason for this is perhaps that the technical aspects of using a poorly defined “blob” of an active hair dye mix behind the ear (applied × 3 and dried), 2 days before hair dyeing are relatively complex for the consumer and/or for hairdressing salon staff. The Colourstart™ system is a simple rub on transfer, applied with the use of a little water to wet it (figure 1), where ease of use is likely to contribute substantially to compliance. Recently, however, a small clinical study cast doubt on whether Colourstart™ would in reality identify much more than half of those at significant risk of a serious adverse reaction to hair dyes [19]. Consequently, in this present work, we designed a more structured study to investigate whether and to what extent the low dose of PPD in the Colourstart™ system would be able to detect sensitivity to PPD in a panel of volunteers with a previous full clinical diagnosis of PPD allergy. Further, to gauge more accurately the practical utility of Colourstart™, groups of 10 patients who had shown 3+, 2+ or 1+ diagnostic patch test reactivity were assessed using Colourstart™ applied according to the manufacturer’s instructions. This study cannot inform directly on the performance of this product in hair dye salon customers, but unless it can be shown to perform adequately in individuals already known to be sensitised, then its practical utility would be open to reasonable challenge. It should be noted that there is no intention here to suggest that the system provides an alternate diagnostic tool; the purpose is to try to gauge the extent to which Colourstart™ has the capacity to provide an alert of a potential problem prior to hair dyeing in a salon.

Materials and methods

The study was given independent ethical approval by Nottingham Research Ethics Committee.

Subjects

30 PPD allergic subjects gave fully informed written consent to participate. Gender (27F, 3M) and age details (range 19-81 years), together with their patch test history are contained in table 1.
Table 1 Details of participants age, gender and patch test history

PPD diagnostic patch test reaction

Age

Gender

Other patch test reactions

+++

19

Female

Caine mix III, DPPD

+++

18

Female

Caine mix III, fragrance mix I, compositae mix, PTD, NPPD, 3 & 4 aminophenol, hydroquinone

+++

19

Female

Caine mix III, fragrance mix II, IPPD, BHT

+++

18

Female

None

+++

52

Female

Ni

+++

47

Male

Fragrance mix II, PTD, NPPD, 3 & 4 aminophenol, tixocortol pivalate

+++

35

Female

PTD

+++

41

Female

Ni, PTD, NPPD, 4-aminophenol

+++

64

Male

Ni, epoxy resin, direct orange 34

+++

46

Female

Caine mix III, Ni, disperse blue mix

++

48

Female

PTD, 4-aminophenol

++

35

Female

PTD, NPPD, resorcinol

++

65

Female

Ni

++

51

Female

Ni

++

59

Female

Neomycin, cobalt, quinoline mix, Balsam of Peru, fragrance mix I, Ni, disperse blue mix, Fragrance mix II, Compositae mix, benzalkonium chloride, framycetin, sodium metabisulphite, caine mix IV

++

43

Female

None

++

42

Female

Epoxy resin, Ni

++

36

Female

None

++

40

Female

Ni, carba mix

++

42

Female

None

+

25

Female

None

+

43

Female

None

+

57

Male

Quaternium 15, MCI/MI

+

47

Female

Caine mix II, budesonide, NPPD, ammonium thioglycolate

+

53

Female

Methyldibromo glutaronitrile

+

36

Female

Ni

+

50

Female

Ni

+

61

Female

Balsam of Peru, EDTA

+

48

Female

Neomycin, Ni

+

81

Female

Balsam of Peru

Materials

Colourstart™ materials were provided as a gift by the manufacturer, Trichocare Diagnostics Ltd, Ridgmont, UK. Colourstart™ has a shelf life of 4 months; all material in this study was well within its use-by date. The Colourstart™ product contains approximately 15 μg of PPD applied uniformly across an area of 0.5 cm2, leading to a dose of 30 μg/cm2.

Protocol

Patches were applied precisely according to the manufacturer’s instructions (figure 2). The test sites were read at approximately 48h and scored both as a simple yes/no, according to whether any sign of a skin reaction was present, but also using the grading scheme for diagnostic patch tests [20], so that there would be a standardised point of comparison. All subjects were invited to report to the hospital at any time, should adverse reactions occur.

Results

Table 1 shows the details of the participants in the study. It is interesting to note that the 3 individuals with a history of a black henna tattoo all were associated with a 3+ diagnostic patch test reaction. table 2 reports the outcome of the application of Colourstart™. All the most allergic individuals reacted to Colourstart™, many relatively strongly. Of the 10 individuals who had a 2+ diagnostic patch test reaction to PPD, 8 reacted to Colourstart™. Thus, 90% of those who were moderately to strongly allergic to PPD according to the diagnostic tested were also positive to Colourstart™. In contrast, only a single individual who was a 1+ reactor to the diagnostic patch test to PPD also reacted to Colourstart™; 9/10 were negative. Examples of the skin reactions obtained to Colourstart™ are given in figure 3 which presents the responses at test sites in six individuals, ranging from no response (A) to both weaker (B-D) and much stronger levels of reaction (E-F).

It is interesting to note that of the 3+ diagnostic patch test reactors, 90% gave either a +++ or a ++ reaction to Colourstart™. Among the 2+ patch test reactors, of the 8 who reacted to Colourstart™, the reactions were generally weaker, with only a single +++ response, whereas 5 gave a + response. The lone 1+ diagnostic patch test reactor who reacted to Colourstart™ also reacted only at the 1+ level to Colourstart™.

None of the subjects reported back to the hospital with strengthening delayed reactions to Colourstart™ after the 48 h scoring point.
Table 2 Results of testing Colourstart™ in 30 PPD allergic subjects

PPD diagnostic patch test reaction

Severity of hair dye reaction

Past henna tattoo reaction

Colourstart™ reaction

Grade of Colourstart™ reaction

+++

Very severe

Yes

Yes

+++

+++

Severe

Yes

Yes

++

+++

Severe

Yes

Yes

+++

+++

None

No

Yes

++

+++

Very severe

No

Yes

+

+++

Severe

No

Yes

+++

+++

Very severe

No

Yes

++

+++

Severe

No

Yes

++

+++

Severe

No

Yes

+++

+++

Very severe

No

Yes

+++

++

Severe

No

Yes

+

++

Severe

No

Yes

++

++

Moderate

No

Yes

+

++

Severe

No

No

Negative

++

Severe

No

Yes

+

++

Very severe

No

Yes

+

++

Very severe

No

Yes

++

++

None

No

Yes

+++

++

Severe

No

Yes

+

++

None

No

No

Negative

+

Severe

No

No

Negative

+

None

No

No

Negative

+

None

No

No

Negative

+

Moderate

No

No

Negative

+

None

No

No

Negative

+

None

No

Yes

+

+

None

No

No

Negative

+

None

No

No

Negative

+

None

No

No

Negative

+

Severe

No

No

Negative

Discussion

Allergy to hair dye is an unfortunately common problem and is one which has usually been attributed to PPD and related chemicals [1-13], although there are reports of cases where PPD or its immediate derivatives are clearly not the skin sensitizer involved [21, 22]. Associated with this is an ongoing effort to identify whether there may be other chemicals in hair dyes which are responsible for hair dye allergy [23]. Whatever the chemicals and chemistry responsible may be however, what remains quite clear is that hair dyes are associated with a distinct frequency of adverse reactions and that the manufacturers continue to suggest that consumers should undertake a sensitivity test prior to use of a hair dye [17, 18]. This self testing is not without its own problems, nor free from criticism [19, 24, 25]. These issues include the basic question of whether such testing in reality constitutes a medical diagnosis which should therefore only be conducted by appropriately qualified personnel and whether the increased exposure to hair dye that must be part of the test process actually contributes to the risk of the induction of hair dye allergy. However, the purpose of the present work has a different intent, that of assessing how well one of the proposed sensitivity testing systems (Colourstart™) performs, not least in the light of a recent critique [19].

Colourstart™ is a skin transfer which contains a small amount of PPD in a hexagonal shape at a dose of 30 μg/cm2. It offers a standardised approach to the identification of individuals with PPD sensitivity via its ease of use and relatively long shelf life. What must be ensured however is that the system functions properly, i.e. that it identifies those with a substantial, potentially problematical degree of PPD allergy. It is already known that PPD allergic individuals whose degree of reactivity is relatively low can generally tolerate exposure and can continue to dye their hair [26]. Of course, this may not be a wise strategy since further exposure risks increasing their reactivity. Such individuals contrast with those who have a greater degree of sensitivity to PPD (giving a 2+ reaction to the diagnostic patch test), of whom only about half say they could continue to dye their hair, and even more so with the most sensitive individuals (those giving a 3+ reaction to the diagnostic patch test), who universally indicate that they can no longer tolerate hair dye exposure [26]. Consequently, a system such as Colourstart™, to be regarded as appropriately functional, must identify all of those who were 3+ and ideally all of those who were2+; identification of 1+ reactors might be regarded as more optional. The results presented here indicate that this is very much how Colourstart™ performed, with all 3+ reactors being picked up as well as 80% of the 2+ reactors. The analysis carried out by Ho and colleagues shows that these are the individuals most at risk of a significant adverse reaction [26]. It is of note that a single 2+ individual who had experienced a severe hair dye reaction was negative to Colourstart™. In the light of the response of the remainder of the test group, one is left to speculate whether in this individual, the hair dye chemical responsible for the severity of her reaction was a material other than PPD and which also does not cross react with it. Consistent with this, the subject was negative on previous patch testing to other hair dyes which normally cross react with PPD, her only other contact allergy being to nickel. Inevitably, a weakness of any system based only on PPD will be that it will not identify sensitivity to hair dye chemicals which are neither PPD nor at least substances that cross react with it well.

The above results with Colourstart™ are at first sight not fully consistent with the recent data reported by Orton, who found that only 3/7 PPD allergic patients responded to Colourstart™. Whilst this overall rate of positivity (43%) is not dramatically different to that of the present study (63%), it is important to examine the patient group involved. In this earlier study, all of the 3+ PPD positives in the diagnostic patch test were also positive to Colourstart™ (although in one case the reaction was weak), a result fully consistent with the present work. Furthermore, all of those (3/3) who were 1+ reactors in the PPD diagnostic patch test were negative to Colourstart, again a result very much consistent with the present observations. This leaves only a single 2+ reactor, who was negative to Colourstart™ in the Orton study; this represents in reality the only real discrepancy. Since in our hands, Colourstart was positive in 80% of 2+ reactors, then the individual in the Orton study could by chance just be one of the “weaker” 2+ diagnostic patch test reactors, a view given credence by their reaction to 1% PPD in petrolatum being 2+ only at 48h and just 1+ at the 96h scoring point.

To identify more of the 1+ reactors (Colourstart™ only identified 10%) would require higher exposure to PPD, which may well be inappropriate, as this must increase the risk of induction of allergy. This might well be argued to be an inappropriate strategy for self test systems such as Colourstart™. As noted in a recent editorial: “A safe, sensitive and reproducible screening self-test would be a welcome tool to prevent severe allergic reactions to hair dye.” [24]. The present work provides a key part of the evidence that this is what Colourstart™ might deliver. The editorial also raises a number of other very pertinent questions, not the least of which is the need for training/guidance of those using self test systems. This might include not only the use and interpretation of the test, but also suitable commentary on its accuracy. Clearly, Colourstart™ is unlikely (by design?) to detect those with only a weak contact allergy to PPD. Furthermore, although it is likely also to detect those individuals with allergy to hair dye chemicals closely related to, and which are known to cross react with, PPD, it will not identify sensitivity to non-PPD related hair dye allergens. For example, although there is considerable cross reaction between PPD and PTD, occasional isolated allergy to PTD is observed [27] and this probably is the explanation for the failure of Colourstart™ to identify the lone PTD allergic individual in the Orton study [19].

Acknowledgements

The authors are grateful to the University of Bedfordshire who provided the necessary funding for this study via the M1 Knowledge Exchange, a Higher Education Innovation Fund initiative.

References

1 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980.

2 Andersen KE, White IR, Goossens A. Paraphenylenediamine: Allergens from the standard series. In: Frosch PJ, Menné T, Lepoittevin J-P, eds. Contact Dermatitis, 4th edition. Heidelberg: Springer-Verlag, 2006: 478-500.

3 White IR. Contact allergy to hair dyes is a well-recognized problem. Clin Exp Dermatol 2006; 31: 724-6.

4 Basketter DA, Lidén C. Further investigation of the prohapten concept: Reactions to benzene derivatives in man. Contact Derm 1992; 27: 90-7.

5 Eilstein J, Giménez-Arnau E, Duché D, Rousset F, Lepoittevin J-P. Mechanistic studies on the lysine-induced N-formylation of 2,5-dimethyl-p-benzoquinonediimine. Chem Res Toxicol 2007; 20: 1155-61.

6 Frosch PJ, Burrows D, Camarasa JG, et al. Allergic reactions to a hairdressers’ series: results from 9 European centres. Contact Derm 1993; 28: 180-3.

7 Sharma VK, Chakrabarti A. Contact sensitizers in Chandigarh, India. A study of 200 patients with the European standard series. Contact Derm 1998; 38: 127-31.

8 Uter W, Lessmann H, Geier J, Schnuch A. Contact allergy to ingredients of hair cosmetics in female hairdressers and clients - an 8-year analysis of IVDK data. Contact Derm 2003; 49: 236-40.

9 Warshaw EM, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group Patch Test Results, 2003-2004 Study Period. Dermatitis 2008; 19: 129-36.

10 Søsted H, Hesse U, Menné T, Andersen KE, Johansen JD. Contact dermatitis to hair dye in an adult Danish population - an interview based study. Br J Dermatol 2005; 153: 132-5.

11 Basketter DA, Duangdeeden I, Gilmour NG, Kullavanijaya P, McFadden J. Prevalence of contact allergy in an adult Thai population. Contact Derm 2004; 50: 128-9.

12 Søsted H, Rastogi SC, Andersen KE, Johansen JD, Menné T. Hair dye contact allergy: quantitative exposure assessment of selected products and clinical cases. Contact Derm 2004; 50: 344-8.

13 Shavit I, Hoffmann Y, Shachor-Meyouhas Y, Knaani-Levinz H. Delayed hypersensitivity reaction from black henna tattoo manifesting as severe facial swelling. Am J Emerg Med 2008; 26: 515; (e3-4).

14 Kluger N, Raison-Peyron N, Guillot B. Tatouages temporaire au henné: des effets indésirables parfois graves. Presse Med 2008; 37: 1138-42.

15 Ljubojević S, Lipozencić J, Zorić Z. Severe allergic hair dye reaction. Acta Dermatovenerologica Croatia 2007; 15: 113.

16 Søsted H, Johansen JD, Andersen KE, Menné T. Severe allergic hair dye reactions in 8 children. Contact Dermatitis 2006; 54: 87-91.

17 Krasteva M, Cristaudo A, Hall B, et al. Contact sensitivity to hair dyes can be detected by the consumer open test. E J Dermatol 2002; 12: 322-6.

18 Krasteva M, Cottin M, Cristaudo A, et al. Sensitivity and specificity of the consumer open skin allergy test as a method of prediction of contact dermatitis to hair dyes. Eur J Dermatol 2005; 15: 18-25.

19 Orton DI. A clinical assessment of a patch test kit marketed to U.K. hairdressers for detecting hair dye allergy. Br J Dermatol 2007; 157: 1017-20.

20 Fregert S. Manual of Contact Dermatitis. 2nd edition. Copenhagen: Munksgaard, 1981.

21 Søsted H, Menné T. Allergy to 3-nitro-p-hydroxyethylaminophenol and 4-amino-3-nitrophenol in a hair dye. Contact Derm 2005; 52: 317-9.

22 Dejobert Y, Piette F, Thomas P. Contact dermatitis to 2-hydroxyethylamino-5-nitroanisole and 3-nitro-p-hydroxyethyl aminophenol in a hair dye. Contact Derm 2006; 54: 217-8.

23 Søsted H, Basketter DA, Estrada E, Johansen JD, Patlewicz GY. Ranking of hair dye substances according to predicted sensitization potency – quantitative structure activity relationships. Contact Derm 2004; 51: 241-54.

24 White JML, White IR. The role of self tests in the diagnosis of hair dye allergy. Br J Dermatol 2007; 157: 847-8.

25 Scientific Committee on Consumer Products. Opinion on sensitivity to hair dyes – consumer self testing. European Commission 2007: adopted December 18th. http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_114.pdf.

26 Ho SGY, Basketter DA, Jefferies D, Rycroft RJG, White IR, McFadden JP. Analysis of para-phenylenediamine allergic patients in relation to strength of patch test reaction. Br J Dermatol 2005; 153: 364-7.

27 Winhoven SM, Rutter KJ, Beck MH. Toluene-2,5-diamine may be an isolated allergy in individuals sensitized by permanent hair dye. Contact Derm 2007; 57: 193.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]